M&A / Deals Isomorphic Labs receives $2.1bn for AI drug development Pharmaceutical TechnologyIsomorphic Labs has secured $2.1bn in funding to expedite its transition from developing AI models to deploying them on a larger scale.Read full story pharminent May 13, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology Isomorphic Labs has secured $2.1bn in funding to expedite its transition from developing AI models to deploying them on a larger scale. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Previous PostNext: Novo, Lilly trade oral GLP-1 data readouts at ECO Related Stories M&A / Deals Arna Pharma and Slate Run complete JV for new US company pharminent May 15, 2026 M&A / Deals Anthropic joins Gates Foundation on $200m health AI pledge pharminent May 15, 2026 M&A / Deals Degron adds $40M to series A, supporting immunology plans for molecular glue platform pharminent May 14, 2026
